Stocks TelegraphStocks Telegraph
Stock Ideas

BIO-B Company Profile and Key Details

NYSE : BIO-B

Bio-Rad Laboratories

$365.08
21.98+6.02%
At Close 4:00 PM

Price Chart

Stock Price Today

Bio-Rad Laboratories, Inc. (BIO-B) stock surged +6.02%, trading at $365.08 on NYSE, up from the previous close of $365.08. The stock opened at $365.08, fluctuating between $365.08 and $365.08 in the recent session.

Stock Snapshot

365.08
Prev. Close
9.99B
Market Cap
365.08
Day Low
-64.28
P/E Ratio
-5.67918
EPS (TTM)
7.58
Cash Flow per Share
365.08
Open
26.92M
Number of Shares
365.08
Day High
N/A
Free Float in %
303.6
Book Value
28
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Sep 01, 2026382.00382.00381.37381.370
Aug 28, 2026387.10387.10387.06387.0626
Aug 26, 2026400.22400.40400.22400.405.37
Aug 25, 2026401.59401.59401.59401.591
Aug 24, 2026388.00388.00388.00388.008.07
Aug 21, 2026365.08365.08365.08365.086
Aug 20, 2026365.08365.08365.08365.08103
Aug 19, 2026364.14364.14364.14364.1417.03
Aug 18, 2026353.34353.34353.34353.340
Aug 14, 2026368.95368.95368.95368.957.03
Aug 11, 2026348.30348.30348.30348.302.01
Aug 07, 2026346.65349.00346.65349.008
Aug 06, 2026338.84359.73338.84359.733
Aug 04, 2026337.00337.00337.00337.005
Aug 03, 2026337.00337.00337.00337.0063
Jul 31, 2026320.50320.50320.50320.500
Jul 28, 2026338.00338.00338.00338.007
Jul 27, 2026338.47338.47320.25320.250
Jul 23, 2026334.43336.89334.43336.893
Jul 22, 2026324.28324.28324.28324.283

Contact Details

Hercules, CA 94547

United States

https://www.bio-rad.com510 724 7000

About Company

Bio-Rad Laboratories, Inc. creates, manufactures, and markets products essential for life science research and clinical diagnostics. Its operations span globally, covering territories such as the United States, Europe, Asia, Canada, and Latin America. The company's business is organized into two main divisions: Life Science and Clinical Diagnostics. The Life Science division develops and provides a comprehensive array of reagents, laboratory apparatus, and instruments. These are vital for various applications, including scientific research methodologies, biopharmaceutical production processes, and food quality testing. This segment dedicates its efforts to key areas within the life sciences, such as proteomics, genomics, biopharmaceutical development, cellular biology, and ensuring food safety. Its diverse clientele includes academic institutions (universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology researchers, and both food producers and testing laboratories. Conversely, the Clinical Diagnostics division specializes in designing, producing, selling, and supporting diagnostic test systems, informatics solutions, test kits, and specific quality control measures for clinical laboratories. This segment furnishes reagents, instrumentation, and software precisely tailored to address particular requirements within the in vitro diagnostics market. Its products are utilized by reference laboratories, hospital labs, state-operated newborn screening facilities, physicians' private offices, and blood transfusion centers. Furthermore, Bio-Rad offers systems and products designed for separating intricate chemical and biological substances, as well as for identifying, analyzing, and purifying their individual components. The company distributes its offerings through a multi-channel approach, leveraging both its direct sales force and a network of distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was established in 1952 and its corporate headquarters are located in Hercules, California.

Company Information

Employees7450
Beta1.11
Sales or Revenue$2.67B
5Y Sales Change%0.191%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Devices

Company Overview

The stock is currently mid-range between its 52-week high and low $244.54 and $387.10. With a market capitalization of about $9.99 billion, Bio-Rad Laboratories, Inc. is classified as a mid-cap and shows market-like volatility (beta ~1.11). Key stats such as the average daily volume over the past year has been around 29.00 shares, in line with its 52-week average. Headquartered in Hercules, CA, Bio-Rad Laboratories, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Norman D. Schwartz, the company employs approximately 7,450 people and listed since September 21, 1999. Bio-Rad Laboratories, Inc. creates, manufactures, and markets products essential for life science research and clinical diagnostics.

Technical Performance

BIO-B has shown mixed momentum, gaining 0.3% over the past week and -1.91% over the past quarter, though year-to-date performance is down -1.91%.

Valuation Metrics

Bio-Rad Laboratories, Inc. trades at a P/E ratio of 44.51, slightly above the S&P 500 average, with a price-to-sales ratio of 3.85 and a price-to-book ratio of 1.38 suggesting the stock is closer to book value. The P/FCF stands at 28.26, also above market averages.

Dividend & Fair Value

Bio-Rad Laboratories, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $156.08. This means the shares are trading above this model’s fair value.

Earnings & Analyst Outlook

Bio-Rad Laboratories, Inc. earnings surprise history is a mixed track record. The quarter that ended August 04, 2026, missed forecasts by 47.19%. The prior quarter beat by -1072.64%. Over the last six quarters, Apple has recorded several small beats. These include 566.86% in August 04, 2025.

Shareholding & Insider Activity

Bio-Rad Laboratories, Inc. has 5.06 million shares outstanding. The public float is 20.89 million shares, elevated short interest at 0.01% of float. This equals 14.00 shares. The short ratio is 0.16 days. Institutional investors hold 4.38% of the float. Insiders own 98.23%. GOETZ JOHN holds 61.17 thousand shares, Magni Giovanni has 20.74 thousand shares and HERTIA JOHN has 18.73 thousand shares.

Frequently Asked Questions

What is the current Bio-Rad Laboratories, Inc. (BIO-B) stock price?
Bio-Rad Laboratories, Inc. (NYSE: BIO-B) stock price is $365.08 in the last trading session. During the trading session, BIO-B stock reached the peak price of $365.08 while $365.08 was the lowest point it dropped to. The percentage change in BIO-B stock occurred in the recent session was 6.02% while the dollar amount for the price change in BIO-B stock was $21.98.
BIO-B's industry and sector of operation?
The NYSE listed BIO-B is part of Medical - Devices industry that operates in the broader Healthcare sector. Bio-Rad Laboratories, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of BIO-B?
No Data
How BIO-B did perform over past 52-week?
BIO-B's closing price is 49.29% higher than its 52-week low of $244.54 where as its distance from 52-week high of $387.10 is -5.69%.
How many employees does BIO-B have?
Number of BIO-B employees currently stands at 7,450.
Link for BIO-B official website?
Official Website of BIO-B is: https://www.bio-rad.com
How do I contact BIO-B?
BIO-B could be contacted at phone 510 724 7000 and can also be accessed through its website. BIO-B operates from 1000 Alfred Nobel Drive, Hercules, CA 94547, United States.
How many shares of BIO-B are traded daily?
BIO-B stock volume for the day was 28 shares. The average number of BIO-B shares traded daily for last 3 months was 29.
What is the market cap of BIO-B currently?
The market value of BIO-B currently stands at $9.99B with its latest stock price at $365.08 and 26.92M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph